Moleculin Biotech's market cap is currently $7.98M. The company's EPS TTM is $-11.691; its P/E ratio is ―; Moleculin Biotech is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -127.00K	$ -222.00K	$ -260.00K	$ -285.00K	$ -185.00K
Operating Income	$ -29.63M	$ -30.64M	$ -22.97M	$ -19.74M	$ -17.52M
EBITDA	$ -29.50M	$ -30.51M	$ -22.80M	$ -19.54M	$ -13.25M
Net Income	$ -29.77M	$ -27.41M	$ -8.86M	$ -15.00M	$ -13.21M
Balance Sheet
Cash & Short-Term Investments	$ 23.55M	$ 43.15M	$ 70.90M	$ 15.17M	$ 10.73M
Total Assets	$ 38.22M	$ 57.42M	$ 84.09M	$ 29.03M	$ 25.23M
Total Debt	$ 574.00K	$ 451.00K	$ 159.00K	$ 277.00K	$ 379.00K
Net Debt	$ -22.98M	$ -42.69M	$ -70.74M	$ -14.90M	$ -10.36M
Total Liabilities	$ 12.14M	$ 5.23M	$ 5.10M	$ 11.27M	$ 9.66M
Stockholders' Equity	$ 26.07M	$ 52.19M	$ 78.99M	$ 17.76M	$ 15.57M
Cash Flow
Free Cash Flow	$ -24.23M	$ -27.71M	$ -18.97M	$ -18.15M	$ -17.25M
Operating Cash Flow	$ -24.10M	$ -27.64M	$ -18.95M	$ -17.77M	$ -17.20M
Investing Cash Flow	$ -124.00K	$ -67.00K	$ -19.00K	$ -374.00K	$ -51.00K
Financing Cash Flow	$ 4.65M	$ -23.00K	$ 74.72M	$ 22.55M	$ 20.85K

Currency in USD

Moleculin Biotech Earnings and Revenue History

Income Statement >

Moleculin Biotech Debt to Assets

Balance Sheet >

Moleculin Biotech Cash Flow

Cash Flow >

Moleculin Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing